National Cancer Institute (NCI) is participating in PA-13-118 Mechanisms, Models, Measurement, & Management in Pain Research (R01)

Notice Number: NOT-CA-13-003

Update: The following update relating to this announcement has been issued:

Key Dates
Release Date: February 22, 2013

Related Notices
PA-13-118
NOT-CA-13-004
NOT-CA-13-005

Issued by
National Cancer Institute (NCI)

Purpose

The purpose of this Notice is to inform potential applicants that the National Cancer Institute (NCI) has been added to the participating components for PA-13-118, entitled "Mechanisms, Models, Measurement, & Management in Pain Research (R01)."

Accordingly, in Part 1. Overview Information, the Components of Participating Organizations section has been revised as shown below to include the NCI:

Components of Participating Organizations

National Institute of Nursing Research (NINR )
National Institute on Aging (NIA )
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD )
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK )
National Institute on Drug Abuse (NIDA )
National Institute of General Medical Sciences (NIGMS )
National Institute of Neurological Disorders and Stroke (NINDS )
National Center for Complementary and Alternative Medicine (NCCAM )
National Cancer Institute (NCI )

In Part 1. Overview Information, the Catalog of Federal Domestic Assistance Numbers section has been revised as shown below to include the appropriate number of the NCI, which is 93.393:

Catalog of Federal Domestic Assistance Numbers

93.361; 93.213; 93.866; 93.853; 93.865; 93.847; 93.859; 93.279; 93.393

In Part 2. Section VII. Agency Contacts, under Scientific/Research Contact(s), the name and contact information for the NCI's program representative are added as follows:

Ann O'Mara, Ph.D., R.N., F.A.A.N.
Division of Cancer Prevention
National Cancer Institute
Telephone: 301-496-8541
E-mail: omaraa@mail.nih.gov

All other aspects of PA-13-118 remain the same.

Inquiries

Please direct all inquiries regarding this Notice to:

Ann O'Mara, Ph.D., R.N., F.A.A.N.
Division of Cancer Prevention
National Cancer Institute
Telephone: 301-496-8541
E-mail: omaraa@mail.nih.gov